Cargando…

MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis

Osteosarcoma (OS) is the most common primary malignant neoplasm of the bone. Recent studies have indicated that the inhibitory effects of microRNA (miR)‐324‐3p could affect the development of numerous cancers. However, its biological roles and underlying mechanisms in OS progression remain unexplore...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Yiping, Duan, Weihao, Yu, Xuecheng, Wu, Furen, Yang, Daibin, Jiang, Yuqing, Wu, Jingbin, Wang, Muyi, Wang, Xin, Shen, Yifei, Zhang, Yunkun, Xu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236611/
https://www.ncbi.nlm.nih.gov/pubmed/36880587
http://dx.doi.org/10.1111/cas.15779
_version_ 1785052974214545408
author Weng, Yiping
Duan, Weihao
Yu, Xuecheng
Wu, Furen
Yang, Daibin
Jiang, Yuqing
Wu, Jingbin
Wang, Muyi
Wang, Xin
Shen, Yifei
Zhang, Yunkun
Xu, Hua
author_facet Weng, Yiping
Duan, Weihao
Yu, Xuecheng
Wu, Furen
Yang, Daibin
Jiang, Yuqing
Wu, Jingbin
Wang, Muyi
Wang, Xin
Shen, Yifei
Zhang, Yunkun
Xu, Hua
author_sort Weng, Yiping
collection PubMed
description Osteosarcoma (OS) is the most common primary malignant neoplasm of the bone. Recent studies have indicated that the inhibitory effects of microRNA (miR)‐324‐3p could affect the development of numerous cancers. However, its biological roles and underlying mechanisms in OS progression remain unexplored. In this study, miR‐324‐3p expression was markedly reduced in OS cell lines and tissues. Functionally, miR‐324‐3p overexpression suppressed OS progression and was involved in the Warburg effect. Mechanistically, miR‐324‐3p negatively regulated phosphoglycerate mutase 1 (PGAM1) expression by targeting its 3′‐UTR. Moreover, high expression of PGAM1 promoted OS progression and aerobic glycolysis, which were associated with inferior overall survival in patients with OS. Notably, the tumor suppressor functions of miR‐324‐3p were partially recovered by PGAM1 overexpression. In summary, the miR‐324‐3p/PGAM1 axis plays an important role in regulating OS progression by controlling the Warburg effect. Our results provide mechanistic insights into the function of miR‐324‐3p in glucose metabolism and subsequently on the progression of OS. Targeting the miR‐324‐3p/PGAM1 axis could be a promising molecular strategy for the treatment of OS.
format Online
Article
Text
id pubmed-10236611
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102366112023-06-03 MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis Weng, Yiping Duan, Weihao Yu, Xuecheng Wu, Furen Yang, Daibin Jiang, Yuqing Wu, Jingbin Wang, Muyi Wang, Xin Shen, Yifei Zhang, Yunkun Xu, Hua Cancer Sci Original Articles Osteosarcoma (OS) is the most common primary malignant neoplasm of the bone. Recent studies have indicated that the inhibitory effects of microRNA (miR)‐324‐3p could affect the development of numerous cancers. However, its biological roles and underlying mechanisms in OS progression remain unexplored. In this study, miR‐324‐3p expression was markedly reduced in OS cell lines and tissues. Functionally, miR‐324‐3p overexpression suppressed OS progression and was involved in the Warburg effect. Mechanistically, miR‐324‐3p negatively regulated phosphoglycerate mutase 1 (PGAM1) expression by targeting its 3′‐UTR. Moreover, high expression of PGAM1 promoted OS progression and aerobic glycolysis, which were associated with inferior overall survival in patients with OS. Notably, the tumor suppressor functions of miR‐324‐3p were partially recovered by PGAM1 overexpression. In summary, the miR‐324‐3p/PGAM1 axis plays an important role in regulating OS progression by controlling the Warburg effect. Our results provide mechanistic insights into the function of miR‐324‐3p in glucose metabolism and subsequently on the progression of OS. Targeting the miR‐324‐3p/PGAM1 axis could be a promising molecular strategy for the treatment of OS. John Wiley and Sons Inc. 2023-03-21 /pmc/articles/PMC10236611/ /pubmed/36880587 http://dx.doi.org/10.1111/cas.15779 Text en © 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Weng, Yiping
Duan, Weihao
Yu, Xuecheng
Wu, Furen
Yang, Daibin
Jiang, Yuqing
Wu, Jingbin
Wang, Muyi
Wang, Xin
Shen, Yifei
Zhang, Yunkun
Xu, Hua
MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis
title MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis
title_full MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis
title_fullStr MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis
title_full_unstemmed MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis
title_short MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis
title_sort microrna‐324‐3p inhibits osteosarcoma progression by suppressing pgam1‐mediated aerobic glycolysis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236611/
https://www.ncbi.nlm.nih.gov/pubmed/36880587
http://dx.doi.org/10.1111/cas.15779
work_keys_str_mv AT wengyiping microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT duanweihao microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT yuxuecheng microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT wufuren microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT yangdaibin microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT jiangyuqing microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT wujingbin microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT wangmuyi microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT wangxin microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT shenyifei microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT zhangyunkun microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis
AT xuhua microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis